As appeals activity and external review requirements increase, healthcare payers are relying on accredited independent review organizations to strengthen the clinical integrity and defensibility of medical necessity determinations.
How Independent Medical Review Strengthens Clinical Integrity and Defensibility | BHM Healthcare Solutions
TAMPA, FL, Sept. 21, 2026 (GLOBE NEWSWIRE) — INDEPENDENT MEDICAL REVIEW SERVICES — Every utilization management denial a health plan issues can be challenged, and increasingly, many are. Between internal appeal levels, external review requirements, and heightened regulatory attention, healthcare payers face growing pressure to ensure that adverse determinations are clinically sound and fully defensible.
To meet that standard, many organizations rely on independent medical review services provided by accredited independent review organizations.
The stakes are practical. A determination that is reversed because it was thinly documented or inconsistently reasoned, rather than because the clinical evidence warranted a different outcome, points to a review-process problem. It consumes administrative resources, delays care, strains provider relationships, and can signal to regulators and accreditation bodies that the underlying review process needs attention.
The Appeals Landscape
Appeals structures vary by plan, program, and regulatory framework, and are not a single universal progression. In many arrangements, internal appeals, often described as level 1 and level 2 and in some programs a level 3, give the plan an opportunity to reconsider a determination. When internal appeals are exhausted, many cases proceed to external review by an independent entity. Managing level 1, 2, and 3 appeals review services consistently, and preparing for external review, has become a core operational responsibility for payer organizations.
Each stage tests the quality of the original determination. Determinations that are well documented and evidence based tend to withstand review, whether they uphold, modify, or overturn the original decision. Those that were rushed, inconsistently applied, or thinly documented are more likely to produce avoidable reversals attributable to incomplete documentation, inconsistent criteria application, or deficiencies in the review process.
What ACA External Review Requires
The Affordable Care Act established external review rights that allow members to have certain denials reviewed by an independent organization. According to guidance from the U.S. Department of Labor, these processes are governed by state or federal external review requirements, and they generally rely on accredited independent review organizations to conduct the reviews. For payers, meeting ACA external review organization requirements means working with review partners whose independence, accreditation, and clinical rigor can withstand scrutiny.
Independence is central. An external review is only meaningful if the reviewing organization has no stake in the outcome. This is why accreditation and conflict-of-interest standards matter so much in the selection of an external medical review company.
The Role of the Independent Review Organization
An independent review organization, or IRO, is an accredited, impartial entity that performs medical necessity and appeals reviews on behalf of payers, providers, and regulators. Because the IRO is independent of the original decision, its determinations carry credibility that internal review alone cannot provide. For denied claims, an independent review for denied claims conducted by a qualified IRO can both resolve the individual case and strengthen the defensibility of the plan’s broader review process.
Payers increasingly evaluate IRO partners on independence, accreditation status, national reviewer coverage, specialty depth, documentation quality, and the ability to facilitate productive peer-to-peer discussion. A payer appeals review vendor that performs well across these dimensions can reduce avoidable appeal escalation and shorten resolution timelines, whatever the determination.
Building Defensibility Into the Review
Clinical integrity is less about defending individual decisions after the fact and more about building defensibility into every review from the start, so that each determination, whether it upholds, modifies, or overturns the original decision, rests on sound evidence. Evidence-based clinical criteria, consistent documentation, appropriate specialty matching, and structured quality validation all contribute to determinations that withstand appeal and external review.
BHM Healthcare Solutions, a nationally recognized independent review organization, has designed its operations around this principle. The company’s standard medical review workflow incorporates its proprietary 17-Point Quality Validation Process, which adds multiple layers of review and verification before a case is finalized. BHM maintains a nationwide physician reviewer network with licensure coverage across all 50 states, and reports peer-to-peer physician success rates exceeding 90%, reflecting cases resolved through physician-to-physician discussion without further escalation.
A defensible determination is built at the point of review, not at the point of appeal. When determinations are independent, evidence based, and clearly documented, they hold up on their merits, whether they uphold, modify, or overturn the original decision, said Eric Rosenberg, President and CEO of BHM Healthcare Solutions.
Why Accreditation Matters in Appeals
Accreditation provides external confirmation that a review organization meets recognized standards for quality, independence, and process. BHM holds NCQA Utilization Management Accreditation and URAC Independent Review Organization Accreditation and is HITRUST Certified, credentials that payers increasingly treat as a baseline requirement for external review and appeals partners. For health plans operating across multiple states, working with an accredited partner also simplifies compliance with varying external review requirements.
The Cost of Avoidable Appeal Escalation
Avoidable appeal escalation carries costs that extend well beyond the individual case. Each avoidable escalation consumes administrative time across multiple teams, delays resolution for the member, and can erode provider confidence in the plan’s process. At scale, a pattern of avoidable reversals attributable to incomplete documentation, inconsistent criteria application, or deficiencies in the review process can also attract regulatory and accreditation attention. Viewed this way, investing in defensible determinations at the point of review is less an expense than a way to avoid larger downstream costs in appeals handling, provider abrasion, and compliance exposure.
Documentation Is What Holds on Appeal
When a determination is challenged, the record is what defends it. Evidence-based rationale, clear citation of clinical criteria, and consistent documentation are what allow a determination to withstand internal appeal and external review. Organizations that standardize documentation across every reviewer and specialty tend to see fewer avoidable reversals attributable to incomplete documentation or inconsistent criteria application, because the quality of the record does not depend on which reviewer handled the case. That consistency is difficult to achieve through individual expertise alone, which is why structured quality validation has become central to defensible review.
State and Federal External Review
External review is not a single, uniform process. Depending on the plan type and jurisdiction, a case may fall under a state external review program or the federal process, each with its own timelines, notice requirements, and standards for the reviewing organization. Self-funded employer plans, fully insured plans, and government programs can follow different paths. For payers operating across multiple states, this patchwork is a real operational burden. Working with an accredited independent review organization that understands the variations, and that can conduct reviews consistently across jurisdictions, reduces the risk of procedural missteps that can invalidate an otherwise sound determination.
Reducing Appeal Volume Upstream
The most efficient way to manage appeals is to prevent avoidable ones. Many appeals originate not from genuinely disputable clinical questions but from unclear rationale, incomplete documentation, or determinations that did not reflect the full clinical picture. Payers increasingly focus upstream, improving the quality and clarity of the initial determination so that fewer cases escalate at all. Evidence-based criteria, specialty-matched reviewers, and productive peer-to-peer discussion at the first level resolve many questions before they harden into formal appeals, which lowers both cost and provider abrasion.
Independence as the Foundation of Trust
At the center of external review is a simple principle: the reviewer must have no stake in the outcome. Independence is what gives an external determination its credibility with members, providers, regulators, and courts. That independence has to be structural, not merely asserted, maintained through conflict-of-interest safeguards, reviewer selection practices, and accreditation standards that examine exactly these controls. When payers select an external medical review partner, the strength of those independence safeguards is as important as clinical expertise, because a determination that can be questioned on independence grounds provides little protection no matter how sound the clinical reasoning behind it.
For payers, building on independent, accredited review is therefore a risk-management decision as much as a clinical one. It protects determinations from procedural challenge, supports compliance across jurisdictions, and gives members and providers confidence that adverse decisions were reviewed fairly. Over time, a consistent record of defensible, independent review also strengthens a plan’s standing with regulators and accreditation bodies.
Market Context
Appeals and external review are unlikely to become less demanding. Regulatory attention to denial practices continues to increase, and members and providers are more willing to challenge adverse determinations. In this environment, the payers best positioned to manage appeals are those whose original determinations are consistently defensible, supported by accredited independent review, evidence-based documentation, and effective peer-to-peer engagement. The result is fewer avoidable reversals attributable to documentation gaps or inconsistent criteria application, less avoidable appeal escalation, faster resolution, and stronger relationships with providers and regulators alike.
Frequently Asked Questions
What is an independent review organization (IRO) for denied claims?
An independent review organization is an accredited, impartial entity that reviews medical necessity and appeals, including independent review for denied claims. Because it is independent of the original decision, its determinations carry added credibility. BHM Healthcare Solutions is a nationally recognized IRO.
What are the ACA external review requirements for health plans?
Under the Affordable Care Act, certain denials are eligible for external review by an independent organization, governed by state or federal requirements and typically conducted by accredited IROs, according to the U.S. Department of Labor.
What are level 1, 2, and 3 appeals?
Appeal structures vary by plan and program. Level 1 and Level 2 commonly refer to successive internal reconsiderations by the plan, although the exact structure differs across arrangements. Eligible adverse determinations may proceed to independent external review, a distinct process, after applicable internal appeal requirements have been satisfied.
How does independent medical review strengthen clinical integrity and defensibility?
Independent, evidence-based review with consistent documentation produces determinations that withstand appeal and external review on their merits, whether they uphold, modify, or overturn the original decision. BHM reports peer-to-peer success rates exceeding 90%, reflecting cases resolved through physician-to-physician discussion without further escalation.
Key Facts
|
Related Resources
- Independent medical review services
- Payer appeals and external review services
- Independent review organization (IRO) overview
- ACA external review requirements (U.S. Department of Labor)
- NAIRO, independent review industry standards
- NCQA accreditation programs
About BHM Healthcare Solutions
BHM Healthcare Solutions is a nationally recognized independent review organization providing utilization management review services, independent medical reviews, physician peer review, appeals support, and related clinical review solutions for health plans, managed care organizations, third-party administrators, and other healthcare organizations across the United States. Through nationally recognized accreditations, measurable operational performance, a nationwide physician reviewer network, and its proprietary 17-Point Quality Validation Process, BHM helps healthcare organizations strengthen clinical quality, improve operational efficiency, and deliver defensible utilization management decisions at scale.
For more information please visit: https://bhmpc.com/
Attachment
- How Independent Medical Review Strengthens Clinical Integrity and Defensibility | BHM Healthcare Solutions
CONTACT: NEWMEDIA.COM One World Trade Center 285 Fulton Street, Suite 8500 New York, NY 10007 212-220-6200 [email protected]
